Volume 3, Issue 9: Controversies in Biologic Therapy for Psoriasis
eMedical Dermatology Review is a monthly CE series for the Dermatology nurse and health care professional. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 3, Issue 9)
Dermatology nurses and health care professionals
Recognize that continuation of methotrexate in patients who are starting biologic therapy because of inadequate response to methotrexate may enhance efficacy.
Determine optimal therapy for patients who lose their response to biologics.
Discuss the impact of biologic treatment for moderate to severe psoriasis on cardiovascular risk.
- 1.00 ANCC